Influence of exercise and menstrual cycle phase on plasma homocyst(e)ine levels in young women - A prospective study

Scandinavian Journal of Medicine and Science in Sports

Volumn 9, Issue 5, 1999, Pages 272-278

  De Crée, Carl ^a,e   Malinow, M R ^b   Van Kranenburg, G P ^a,c   Geurten, P G ^a,c   Longford, N T ^d   Keizer, H A ^a,c  

^a UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d DE MONTFORT UNIVERSITY   (United Kingdom)

^e IGER   (Belgium)

Author keywords

Cardiovascular disease; Catechotestragens; Estrorjens; Exercise; Female athletes; Homocysteine; Menstrual cycle

Indexed keywords

HOMOCYSTEINE;

ADOLESCENT; ARTICLE; BLOOD; CLINICAL TRIAL; EXERCISE; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; PHYSIOLOGY; PROSPECTIVE STUDY;

ADOLESCENT; EXERCISE; FEMALE; FOLLICULAR PHASE; HOMOCYSTEINE; HUMANS; LUTEAL PHASE; PROSPECTIVE STUDIES;

EID: 0033209649     PISSN: 09057188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0838.1999.tb00245.x     Document Type: Article

References (37)

1. Lentz SR. Mechanisms of thrombosis in hypcrhomocysteinemia. Curr Opin Hematol 1998: 5: 343-9.
2. Douglas PS, Clarkson TB, Flowers NC. Exercise and atherosclerotic heart disease in women. Med Sci Sports Exerc 1992: 24: S266-76.
3. Taylor PA, Ward A. Women, high-density lipoprotein cholesterol, and exercise. Arch Intern Med 1993: 153: 1178-84.
4. Kraus RM. Exercise, lipoproteins, and coronary artery disease. Circulation 1989: 79: 1143-5.
5. Nygård O, Vollset SE, Refsum H. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 1995: 274: 1526-33.
6. Rosano GM, Sarrel PM, Poole-Wilson PA. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993: 342: 133-6.
7. De Crée C. van Kranenburg G, Geurten P, Fujimori Y, Keizer HA. Exercise-induced changes in enzymatic Omethylation of catecholestrogens by erythrocytes of eumenorrheic women. Med Sci Sports Exerc 1997: 29: 1580-7.
8. De Crée C. van Kranenburg G, Geurten P, Fujimori Y, Keizer HA. 4-Hydroxy-catecholestrogen metabolism ré ponses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer. Fertil Steril 1997: 67: 505-16.
9. Malinow MR, Kang SS, Taylor LM. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989: 79: 1180-8.
10. De Crée C, Ball P, Seidlitz B, van Kranenburg G, Geurten P, Keizer HA. Plasma 2-hydroxycatecholestrogen responses to acute submaximal and maximal exercise in untrained women. J Appl Physiol 1997: 82: 363-70.
11. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 1979: 37: 247-8.
12. Longford NT. Random coefficient models. Oxford, UK: Oxford University Press, 1993.
13. Becker RA, Chambers JM, Wilks AR. The new S-language. A programming environment for data analysis and graphics. Pacific Grove. CA: Wadsworth and Brooks/Cole Publ., 1988.
14. Peipert JF, Metheney WP, Schulz K. Sample size and statistical power in reproductive research. Obstet Gynecol 1995: 86: 302-5.
15. Kramer HC, Thiemann S. How many subjects? Statistical power analysis in research. Newbury Park, CA: Sage Press Publ., 1987.
16. Franks BD, Huck SW. Why does everyone use the 0.05 significance level. Res Q Exerc Sport 1986: 57: 245-9.
17. Skipper JK, Jr, Guenther AL, Nass G. The sacredness of 0.05: A note concerning the uses of statistical levels of significance. In: Morrison DE, Henkel RE (eds). The significance test controversy. Chicago: Aldine Publ, 1970: 155-60.
18. Guyatt G, Jaeshke R, Heddle N. Basic statistics for clinicians: 1. Hypothesis testing. CMAJ 1995: 152: 27-32.
19. Dohm GL, Beecher GR. Warren RQ. Influence of exercise on free amino acid concentrations in rat tissues. J Appl Physiol 1981: 50: 41-4.
20. Locke M, Noble EG, Atkinson BG. Exercising mammals synthesize stress proteins. Am J Physiol 1990: 258: C723-9.
21. Brattström L, Lindgren A, Israelsson B. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationship to type of stroke and stroke risk factors. Eur J Clin Invest 1992: 22: 214-21.
22. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989: 114: 473-501.
23. Boers GA, Small AG, Trybels FJ. Unique efficiency of methionine metabolism in pre-menopausal women may protect against vascular disease in the reproductive years. J Clin Invest 1983: 72: 1971-6.
24. Steegers-Theunissen RP, Boers GH, Steegers E.A. Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study. Contraception 1992: 45: 129-39.
25. Brattström L, Israelsson B, Olsson A. Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated proslatic carcinoma. Scand J Clin Lab Invest 1992: 52: 283-7.
26. Wouters MG, Moorrees MT, van der Mooren MJ. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995: 25: 801-5.
27. Giltay EJ, Hoogeveen EK, Elbers JMH. Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females. J Clin Endocrinol Metab 1998: 83: 550-3.
28. Thompson DL, Snead DB, Seip RF. Serum lipid levels and steroidal hormones in women runners with irregular menses. Can J Appl Physiol 1997: 22: 66-77.
29. Keizer HA, Rogol AD. Physical exercise and menstrual cycle alterations. What are the mechanisms? Sports Med 1990: 10: 218-35.
30. Lamon-Fava S, Fisher EC, Nelson ME. Effect of exercise and menstrual cycle status on plasma lipids, low density lipoprotein particle size, and apolipoproteins. J Clin Endocrinol Metab 1989: 68: 17-21.
31. Kang S-S, Wong PW, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992: 12: 279-98.
32. Chute CG, Baron JA, Plymate SR. Sex hormone and coronary artery disease. Am J Med 1987: 83: 853-9.
33. Fischer GM, Swain ML. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis 1985: 54: 177-85.
34. Collins P, Estrogen and cardiovascular dynamics. Am J Sports Med 1996: 24: S30-2.
35. Blundell G, Jones BG, Rose FA. Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis 1996: 122: 163-72.
36. Stamler JS, Osborne JA, Jaraki O. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993: 91: 308-18.
37. Ayres S, Ablanalp W, Liu JH. Mechanisms involved in the protective effect of estradiol-17α on lipid peroxidation and DNA damage. Am J Physiol 1998: 274 (Endocrinol Metab 37): E1002 8.